DK161520C - Analogifremgangsmaade til fremstilling af penemderivater og mellemprodukter til anvendeles ved fremgangsmaaden - Google Patents

Analogifremgangsmaade til fremstilling af penemderivater og mellemprodukter til anvendeles ved fremgangsmaaden

Info

Publication number
DK161520C
DK161520C DK533779A DK533779A DK161520C DK 161520 C DK161520 C DK 161520C DK 533779 A DK533779 A DK 533779A DK 533779 A DK533779 A DK 533779A DK 161520 C DK161520 C DK 161520C
Authority
DK
Denmark
Prior art keywords
procedure
peneme
intermediates
derivatives
preparation
Prior art date
Application number
DK533779A
Other languages
Danish (da)
English (en)
Other versions
DK161520B (da
DK533779A (da
Inventor
Marcel Menard
Alain Martel
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of DK533779A publication Critical patent/DK533779A/da
Publication of DK161520B publication Critical patent/DK161520B/da
Application granted granted Critical
Publication of DK161520C publication Critical patent/DK161520C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C247/00Compounds containing azido groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/09Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/88Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • C07F7/081Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/10Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/568Four-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6536Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
    • C07F9/6539Five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65611Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system (X = CH2, O, S, NH) optionally with an additional double bond and/or substituents, e.g. penicillins and analogs
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
DK533779A 1978-12-18 1979-12-14 Analogifremgangsmaade til fremstilling af penemderivater og mellemprodukter til anvendeles ved fremgangsmaaden DK161520C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96866378A 1978-12-18 1978-12-18
US96866378 1978-12-18

Publications (3)

Publication Number Publication Date
DK533779A DK533779A (da) 1980-06-19
DK161520B DK161520B (da) 1991-07-15
DK161520C true DK161520C (da) 1991-12-23

Family

ID=25514601

Family Applications (5)

Application Number Title Priority Date Filing Date
DK533779A DK161520C (da) 1978-12-18 1979-12-14 Analogifremgangsmaade til fremstilling af penemderivater og mellemprodukter til anvendeles ved fremgangsmaaden
DK533879A DK533879A (da) 1978-12-18 1979-12-14 Penem-forbindelser og mellemprodukter og fremgangsmaader til fremstilling deraf
DK237690A DK237690D0 (da) 1978-12-18 1990-10-01 Azetidinonderivater
DK236590A DK161970C (da) 1978-12-18 1990-10-01 Azetidinonderivater
DK911352A DK135291D0 (da) 1978-12-18 1991-07-15 Azetidinonderivater

Family Applications After (4)

Application Number Title Priority Date Filing Date
DK533879A DK533879A (da) 1978-12-18 1979-12-14 Penem-forbindelser og mellemprodukter og fremgangsmaader til fremstilling deraf
DK237690A DK237690D0 (da) 1978-12-18 1990-10-01 Azetidinonderivater
DK236590A DK161970C (da) 1978-12-18 1990-10-01 Azetidinonderivater
DK911352A DK135291D0 (da) 1978-12-18 1991-07-15 Azetidinonderivater

Country Status (13)

Country Link
JP (1) JPS60222486A (fi)
AU (4) AU541717B2 (fi)
CA (2) CA1286661C (fi)
CH (2) CH643265A5 (fi)
DK (5) DK161520C (fi)
ES (1) ES487034A0 (fi)
FI (2) FI67853C (fi)
GR (2) GR81420B (fi)
IE (3) IE50597B1 (fi)
IL (2) IL58576A (fi)
SE (5) SE454779B (fi)
YU (4) YU43628B (fi)
ZA (2) ZA796812B (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8509180D0 (en) * 1985-04-10 1985-05-15 Erba Farmitalia Penem derivatives
US4826832A (en) * 1986-05-06 1989-05-02 Ciba-Geigy Corporation Penen compounds
ATE253070T1 (de) * 1995-02-17 2003-11-15 Daiichi Suntory Pharma Co Ltd Penem-derivate und sie enthaltende anti- mikrobische mittel
ATE283707T1 (de) 1998-01-13 2004-12-15 Daiichi Suntory Pharma Co Ltd Antibakterille zusammensetzung zur topischen anwendung, enthaltend faropenem
JP2005239696A (ja) 2004-01-30 2005-09-08 Daiichi Suntory Pharma Co Ltd 無機物質を配合した医薬硬質カプセル剤
CN112746066B (zh) * 2021-01-25 2023-10-31 洛阳华荣生物技术有限公司 一种l-赖氨酸脱羧酶突变体及其应用

Also Published As

Publication number Publication date
YU43628B (en) 1989-10-31
DK237690A (da) 1990-10-01
AU3240884A (en) 1984-12-13
YU43280B (en) 1989-06-30
AU539983B2 (en) 1984-10-25
IL58804A (en) 1986-03-31
DK533879A (da) 1980-06-19
CH643846A5 (en) 1984-06-29
IL58576A0 (en) 1980-01-31
YU215782A (en) 1983-06-30
SE7910390L (sv) 1981-06-18
AU563015B2 (en) 1987-06-25
FI69845B (fi) 1985-12-31
SE454779B (sv) 1988-05-30
YU42125B (en) 1988-04-30
SE8405719D0 (sv) 1984-11-14
DK236590D0 (da) 1990-10-01
DK161970B (da) 1991-09-02
YU215382A (en) 1983-06-30
SE8405813L (sv) 1984-11-19
AU5371079A (en) 1980-06-26
SE7910391L (sv) 1981-06-18
YU307679A (en) 1983-02-28
IL58804A0 (en) 1980-02-29
ES8101594A1 (es) 1980-12-16
AU5378779A (en) 1980-08-28
DK161520B (da) 1991-07-15
DK135291A (da) 1991-07-15
GR74491B (fi) 1984-06-28
IE851853L (en) 1980-06-18
ZA796813B (en) 1981-05-27
YU43464B (en) 1989-08-31
AU3288484A (en) 1985-03-07
YU276079A (en) 1983-02-28
IE49877B1 (en) 1986-01-08
SE8405813D0 (sv) 1984-11-19
IE852246L (en) 1980-06-18
DK237690D0 (da) 1990-10-01
FI67853B (fi) 1985-02-28
SE461395B (sv) 1990-02-12
IE50597B1 (en) 1986-05-28
DK135291D0 (da) 1991-07-15
FI69845C (fi) 1986-05-26
AU557545B2 (en) 1986-12-24
FI793903A (fi) 1980-06-19
GR81420B (fi) 1984-12-11
CH643265A5 (en) 1984-05-30
SE8405719L (sv) 1984-11-14
FI67853C (fi) 1985-06-10
ES487034A0 (es) 1980-12-16
SE8405812D0 (sv) 1984-11-19
ZA796812B (en) 1981-05-27
IE792462L (en) 1980-06-18
CA1286661C (en) 1991-07-23
DK533779A (da) 1980-06-19
AU541717B2 (en) 1985-01-17
DK161970C (da) 1992-02-03
DK236590A (da) 1990-10-01
IE49876B1 (en) 1986-01-08
FI793905A (fi) 1980-06-19
SE464027B (sv) 1991-02-25
CA1268183A (en) 1990-04-24
IL58576A (en) 1985-12-31
JPS60222486A (ja) 1985-11-07
SE8405812L (sv) 1984-11-19
SE448995B (sv) 1987-03-30

Similar Documents

Publication Publication Date Title
DK46079A (da) Fremgangsmaade til fremstilling af alkylendiaminderivater
DK158225C (da) Analogifremgangsmaade til fremstilling af carbostyrilderivater
DK163832C (da) Analogifremgangsmaade til fremstilling af cephemforbindelser og mellemprodukter til anvendelse ved fremgangsmaaden
DK325079A (da) Fremgangsmaade til fremstilling af tiazolidinderivater
DK365079A (da) Fremgangsmaade til fremstilling af 1-alfa-hydroxylerede calciferoler
DK156779A (da) Fremgangsmaade til fremstilling af cycloalkyltriazoler
DK129879A (da) Fremgangsmaade til fremstilling af n-heterocyclyl-4-piperidinaminer
DK266479A (da) Fremgangsmaade til fremstilling af 3-aminopropoxyarylderivater
DK303079A (da) Fremgangsmaade til fremstilling af imidazolderivater
DK268579A (da) Fremgangsmaade til fremstilling af phenetamolaminer
DK186179A (da) Fremgangsmaade til fremstilling af carbapenemderivater
DK307279A (da) Fremgangsmaade til fremstilling af phenolethere
DK113079A (da) Fremgangsmaade til fremstilling af n-oxacyclylalkyl-piperidyl-diazaforbindelser og anvendelsen deraf
DK265779A (da) Fremgangsmaade til fremstilling af o-methallyloxyphenol
DK415379A (da) Fremgangsmaade til fremstilling af chromanolderivater
DK433779A (da) Fremgangsmaade til fremstilling af phenylquinolizidiner
DK150471C (da) Fremgangsmaade til fremstilling af trifluormethylphenoler
DK161520C (da) Analogifremgangsmaade til fremstilling af penemderivater og mellemprodukter til anvendeles ved fremgangsmaaden
DK160281C (da) Fremgangsmaade til fremstilling af steroid-s-thioesterderivater
DK145179A (da) Fremgangsmaade til fremstilling af 4-methyl-5-hydroxymethyl-imidazol
DK348179A (da) Fremgangsmaade til fremstilling af carbazolyderivater
DK428079A (da) Fremgangsmaade til fremstilling af cyclohexadienderivater
DK157017C (da) Analogifremgangsmaade til fremstilling af carbostyrilderivater
DK239279A (da) Fremgangsmaade til fremstilling af 2-oximinophenylacetonitril
DK185179A (da) Fremgangsmaade til fremstilling af 3-halogen-2-hydroxyalkyltrialkylammoniumunchlorider

Legal Events

Date Code Title Description
PBP Patent lapsed